flurouracil. Clinical examination which was done on carcinomas of the bulbomembranous urethra are
completion of the chemotherapy treatment of squamous cell origin in 80%, of transitional cell
revealed marked decrease in the size of the mass, origin in 10%, and adenocarcinoma or
3
although still palpable, and closure of the scrotal undifferentiated in 10% .
sinus. Staging of the tumour includes clinical
Repeat CT scan confirmed the clinical findings examination, cystoscopy, and bimanual palpation to
and did not detect any abdominal lymphadenopathy evaluate the extent of local involvement of the
(Figure 3). The patient was scheduled for radical tumor. Transurethral or needle biopsy of the lesion,
penectomy, scrotectomy, cystoprostatectomy, pelvic and of the prostate if indicated, is also performed as
lymphadenectomy and urinary diversion ( ileal part of the staging (Table 1).
conduit ). The mass was excised with difficulty, as it
was attached to the iliac bone and to the rectum. Table 1. Clinical-pathologic staging for
Accidental rectal injury was encountered during urethral cancer
excision of the bladder and was primarily repaired
using vicryl and anal dilatation. Figures 4 and 5 show
the external genitalia and the excised bladder . The
testes were inserted into an inguinal pouch
bilaterally. The perineal wound was left open for
future skin graft.
The patient developed rectal fistula to the
perineal wound. This closed in 10 days of low
residue diet. The perineal wound was subsequently
covered with skin graft.
The pathological specimen showed a locally
advanced high grade transitional cell carcinoma of
the urethra with local extension to the corpus
cavernosum. The surgical margin was free of
tumour and the lymph nodes showed reactive
lymphadenopathy. There was no evidence of
squamous cell cancer in the specimen. In addition, a
focal prostatic adenocarcinoma with Gleason score
of 6 (3+3) was demonstrated within the prostate
specimen.
Due to the nature of the tumour, the patient was
administered adjuvant chemo-radiotherapy using
Urethral cancer staging in accordance with the criteria
Gemcitabin and Cisplatinum with local radiation to outlined by the American Joint Committee on Cancer
the pelvis and the perineum. The patient remains Staging System
disease free six months post treatment.
No consensus has been reached regarding the
Discussion optimal therapeutic approach for urethral tumours
due to the small number of patients treated at
The histologic subtype of urethral cancer varies by individual institutions. The overall management
anatomic location. Carcinomas of the prostatic depends on the site and the stage of the tumor.
urethra are of transitional cell origin in 90% and of Distal urethral tumours are usually of low stage
squamous cell origin in 10%, carcinomas of the and are amenable to local excision with good overall
penile urethra are of squamous cell origin in 90% prognosis. On the contrary, proximal urethral
and of transitional cell origin in 10%, and tumours present with higher stage require
Port Harcourt Medical Journal 2007; 1: 208-211 210
Local advanced transitional cell cancer E.H. Abdel Goad, T. De Bastiani and S. Ramksoon
Tx
T0
Ta
Primary tumor cannot be assessed
No evidence of primary tumor
Noninvasive papillary, polypoid, or
verrucous carcinoma
Tis
T1
Carcinoma in situ
Tumor invades subepithelial connective
tissue
T2
Tumor invades any of the following :
corpus spongiosum, prostate, periurethral
muscle
T3
Tumor invades any of the following:
corpus cavernosum, beyond prostate
capsule, anterior vagina, bladder neck
T4
Tumor invades other adjacent organs
Regional
lymph nodes (N)
Nx
Regional lymph nodes cannot be assessed
N0
No regional lymph nodes metastasis
N1
Metastasis in a single lymph node, 2 cm
or less in greatest dimension
N2 Metastasis in a single lymph node, more
than 2 cm in greatest dimension, or in
multiple lymph nodes
Distant
metastasis (M)
Mx Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metatasis
Primary tumor (T) (men and women)